These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9666903)

  • 1. Parkinson's disease and the eye.
    Armstrong RA
    Ophthalmic Physiol Opt; 1997 Sep; 17 Suppl 2():S9-16. PubMed ID: 9666903
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in Parkinson's disease.
    Schapira AH
    Eur J Neurol; 2008 Jan; 15(1):1. PubMed ID: 18171385
    [No Abstract]   [Full Text] [Related]  

  • 3. Oculomotor dysfunction in Parkinson's disease.
    Corin MS; Elizan TS; Siegel GJ
    Trans Am Neurol Assoc; 1970; 95():226-9. PubMed ID: 5514375
    [No Abstract]   [Full Text] [Related]  

  • 4. Oculomotor function in patients with Parkinson's disease.
    Corin MS; Elizan TS; Bender MB
    J Neurol Sci; 1972 Mar; 15(3):251-65. PubMed ID: 5014091
    [No Abstract]   [Full Text] [Related]  

  • 5. Sleep disorders in Parkinson's disease.
    Larsen JP
    Adv Neurol; 2003; 91():329-34. PubMed ID: 12442690
    [No Abstract]   [Full Text] [Related]  

  • 6. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
    Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):34-5. PubMed ID: 18323765
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamic characteristics of saccadic eye movements in Parkinson's disease.
    Jones GM; DeJong JD
    Exp Neurol; 1971 Apr; 31(1):17-31. PubMed ID: 5554972
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairment of function of the extraocular muscles in Parkinson's disease.
    Chaco J
    Ophthalmologica; 1971; 162(6):343-7. PubMed ID: 5131966
    [No Abstract]   [Full Text] [Related]  

  • 9. Square-wave action dystonia in Parkinson's disease.
    van den Munckhof P; Lenz FA; Chase TN
    Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355
    [No Abstract]   [Full Text] [Related]  

  • 10. [Visual-oculomotor and vestibular-oculomotor abnormalities in Parkinson's disease].
    Kaźmierczak H; Gospodarek T; Harat M; Pawlak-Osińska K; Gospodarek G
    Otolaryngol Pol; 2006; 60(1):21-4. PubMed ID: 16821536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment.
    Mehta SH; Morgan JC; Sethi KD
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):6-11. PubMed ID: 18323761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for Parkinson's disease.
    Med Lett Drugs Ther; 2017 Nov; 59(1534):187-194. PubMed ID: 29136401
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison table: drugs for Parkinson's disease.
    Med Lett Drugs Ther; 2017 Nov; 59(1534):e194-e196. PubMed ID: 29136402
    [No Abstract]   [Full Text] [Related]  

  • 14. Akinesia, hypokinesia, and bradykinesia in the oculomotor system of patients with Parkinson's disease.
    DeJong JD; Jones GM
    Exp Neurol; 1971 Jul; 32(1):58-68. PubMed ID: 5095610
    [No Abstract]   [Full Text] [Related]  

  • 15. Ipsilateral pupil dilation associated with unilateral intermittent exotropia: a new observation.
    Dunlop C
    Clin Exp Ophthalmol; 2011 Nov; 39(8):839-41. PubMed ID: 21794049
    [No Abstract]   [Full Text] [Related]  

  • 16. Future strategies for the treatment of Parkinson's disease.
    Fahn S
    Adv Neurol; 1993; 60():636-40. PubMed ID: 8420202
    [No Abstract]   [Full Text] [Related]  

  • 17. Professional development. Parkinson's disease: knowledge for practice (continuing education credit).
    Nurs Times; 1996 Jan 3-9; 92(1):suppl 1-4. PubMed ID: 8684938
    [No Abstract]   [Full Text] [Related]  

  • 18. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of motor complications in treatment of Parkinson's disease.
    Kumar A; Huang Z; de la Fuente-Fernández R
    Adv Neurol; 2003; 91():193-201. PubMed ID: 12442678
    [No Abstract]   [Full Text] [Related]  

  • 20. Extended-release amantadine (Gocovri) for dyskinesia in Parkinson's disease.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):198-200. PubMed ID: 29186084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.